A novel histopathological feature of spatial tumor–stroma distribution predicts lung squamous cell carcinoma prognosis

Tetsuro Taki,Yutaro Koike,Masahiro Adachi,Shingo Sakashita,Naoya Sakamoto,Motohiro Kojima,Keiju Aokage,Shumpei Ishikawa,Masahiro Tsuboi,Genichiro Ishii
DOI: https://doi.org/10.1111/cas.16244
IF: 5.7
2024-09-04
Cancer Science
Abstract:We propose a cutting‐edge framework for assessing cancer tissues, with a special emphasis on the spatial interaction between cancer cells and the stromal environment. This framework provides a novel perspective in gauging malignancy and forecasting patient prognosis in squamous cell carcinoma, traditionally evaluated mainly through pathological staging. We used a mathematical approach to investigate the quantitative spatial profile of cancer cells and stroma in lung squamous cell carcinoma tissues and its clinical relevance. The study enrolled 132 patients with 3–5 cm peripheral lung squamous cell carcinoma, resected at the National Cancer Center Hospital East. We utilized machine learning to segment cancer cells and stroma on cytokeratin AE1/3 immunohistochemistry images. Subsequently, a spatial form of Shannon's entropy was employed to precisely quantify the spatial distribution of cancer cells and stroma. This quantification index was defined as the spatial tumor–stroma distribution index (STSDI). The patients were classified as STSDI‐low and ‐high groups for clinicopathological comparison. The STSDI showed no significant association with baseline clinicopathological features, including sex, age, pathological stage, and lymphovascular invasion. However, the STSDI‐low group had significantly shorter recurrence‐free survival (5‐years RFS: 49.5% vs. 76.2%, p
oncology
What problem does this paper attempt to address?